SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
about
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
description
im Januar 2019 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 01 March 2019
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в січні 2019
@uk
name
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@en
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@nl
type
label
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@en
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@nl
prefLabel
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@en
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@nl
P2093
P50
P356
P1476
SHH pathway inhibition is protumourigenic in adamantinomatous craniopharyngioma
@en
P2093
A Virasami
J K R Boult
L Panousopoulos
L S Danielson
P304
P356
10.1530/ERC-18-0538
P407
P577
2019-03-01T00:00:00Z